Genentech
HEMLIBRA
Manufacturer:
Genentech
Name:
HEMLIBRA
HCPCS Code Descriptor:
Injection, emicizumab-kxwh, 0.5 mg
Category:
J Code
HCPCS:
J7170
NDC(s):
50242-0923-01, 50242-0921-01, 50242-0922-01, 50242-0920-01
Primary Type:
Hematology
Generic Status:
Single-Source
Route of Administration:
Subcutaneous
About:
HEMLIBRA is a Hematology drug manufactured by Genentech and administered via the Subcutaneous route of administration. The J Code: J7170 is aligned to the drug HEMLIBRA.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/19
HCPCS Effective Date:
1/1/19
HCPCS Short Description:
Inj., emicizumab-kxwh 0.5 mg
Billing and Coding Guide:
https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/Hemlibra-Billing-Coding-for-Hemophilia-A.pdf
Patient Assistance:
https://www.gene.com/patients/patient-foundation